in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Halocarbon Poised to Sell Sevoflurane
9:36 AM MDT | June 27, 2008 | Alex Scott in Münich
Alex Scott in Münich
Specialty fluorochemicals producer Halocarbon (River Edge; NJ) says it is about to begin selling the fluorinated anesthetic sevoflurane in large volumes in the U.S. following FDA approval. Sevoflurane is currently produced by two major pharma companies in a multi-billion dollar market. “If we secured 5% of the market that would be nice,” says Ron Epstein, sales director/Halocarbon, speaking at the recent Chemspec Europe specialty chemicals expo in Münich. The company says it has yet to decide whether to sell the product directly or...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee